KRAS and pancreatic neoplasm: In the case of MiaPaCa-2 cells (human pancreatic tumor cells with an activating mutation in the KRAS gene), the two most effective statins, pitavastatin and cerivastatin, had the most significant effect on the cell cycle; an increase in the number of cells was evident in the G0/G1 phase.